Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide.
作者信息
Bengtsson D, Schrøder H D, Berinder K, Maiter D, Hoybye C, Ragnarsson O, Feldt-Rasmussen U, Krogh Rasmussen Å, van der Lely A, Petersson M, Johannsson G, Andersen M, Burman P
机构信息
Department of Endocrinology, Kalmar, Kalmar County Council and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Department of Pathology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
出版信息
Endocrine. 2018 Dec;62(3):737-739. doi: 10.1007/s12020-018-1751-9. Epub 2018 Sep 24.
PMID:30246233
Abstract
摘要
Zotero 插件